Insights on Life Sciences
Article
Closing the women’s health gap: Biopharma’s untapped opportunity
-
Most top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately, putting them in a prime position to close the sex- and gender-based health gap.
Article
Gen AI: A game changer for biopharma operations
-
From the shop floor to the supply chain, gen AI can transform how biopharma companies operate. Four use cases show how it can...
Article
Scaling gen AI in the life sciences industry
-
Gen AI pilots have shown promise, but for the technology to deliver transformational business value in the life sciences industry,...
Article
The hidden traps of business building: A guide for life science CEOs
-
CEOs in pharma, biotech, and medtech are increasingly building patient-centric businesses but are struggling to do so. Avoiding...
Article
Building a shared vision for pharma R&D–supplier partnerships
-
Pharma R&D leaders and their suppliers see transparency as a key to unlocking more effective collaborations and cost efficiencies....
Article
Operational excellence in biopharma research and early development
-
Leading companies are revamping research and early development to curb lengthy drug development timelines and rising costs.
Article
Unlocking peak operational performance in clinical development with artificial intelligence
-
Three lighthouse use cases serve as a blueprint for AI’s potential to improve the speed, efficiency, and quality of clinical...
Article
Putting people at the center of the R&D talent model in life sciences
-
Rapid advancements in science and technology are challenging pharma and biotech companies’ approaches to talent. What R&D...
Article
Strengthening the R&D operating model for pharmaceutical companies
-
Revisiting the operating model could help pharmaceutical companies improve R&D productivity.
Article
How biopharmaceutical leaders optimize their portfolio strategies
-
Leading biopharmaceutical companies manage their clinical pipelines to optimize for risk and reward. Here’s how.
Article
Charting the path to patients
-
Careful development of asset strategy across the pharmaceutical R&D pipeline is increasingly important in embracing opportunities...
Article
Small but mighty: Priming biotech first-time launchers to compete with established players
-
Biotechs making their commercial debut can improve their launch success rate and overall financial performance by learning from...
Article
Value creation priorities shaping medtech
-
With pandemic-related volatility subsiding, the strategies separating industry leaders from their peers are coming into focus....
Podcast
Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO
-
As head of R&D at Novo Nordisk, Marcus Schindler is leading the company’s efforts to embrace external innovation and...
Video
The potential for AI to change cancer drug discovery and development
The impending AI-driven life science revolution promises to transform human health and well-being.
Article
Making more medicines that matter
-
Productivity in biopharmaceutical R&D has slumped for a decade or more. We propose a recipe for sustainable, value-creating...
Interview
Spurring innovation in animal health: An interview with Elanco’s Jeff Simmons
-
The 35-year industry veteran stresses the need for creation over commoditization as the growing animal health sector continues...
Special collection
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
Coronavirus vaccines progress: What’s next?
The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.
The rise of health technology
Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.
More insights
Related Practices
Healthcare Systems & Services
Read our latest research, articles, and reports on Healthcare Systems & Services on the changes that matter most for the...
Consumer Health
The consumer-health industry is booming, driven by an aging population, a proliferation of wellness-related products and services,...
Public & Social Sector
Read our latest research, articles, and reports on Public & Social Sector.